On September 19th, 2022, the NMPA (National Medical Products Administration) issued a notice on the launch of the new version of the National Cosmetic Adverse Reaction Monitoring System.
Key points of this notice…
Sorry, this premium content is for RegASK clients only.
Want to access the whole content of the alert or browse all the news?
Subscribe to the latest regulatory news
Curated newsletters
Relevant industry info
Access expert insights
